Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 18961 - 18980 out of 485363 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices | Injection 108 mg in 0.68 mL single use pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices | Injection 108 mg in 0.68 mL single use pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices | Injection 108 mg in 0.68 mL single use pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices | Injection 108 mg in 0.68 mL single use pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices | Injection 108 mg in 0.68 mL single use pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 108 mg/0.68 mL injection, 2 x 0.68 mL pen devices | Injection 108 mg in 0.68 mL single use pre-filled pen, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 300 mg powder for injection, 1 vial | Powder for injection 300 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG05) vedolizumab (adm: P) | Entyvio 300 mg powder for injection, 1 vial | Powder for injection 300 mg, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TakedaPharmaceuticalsAustraliaPty.Ltd. |
| Australia | (L04AG08) ocrelizumab (adm: P) | Ocrevus 300 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 300 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | RocheProductsPtyLtd |
| Australia | (L04AG11) anifrolumab (adm: P, previous atc code l04aa51. new atc 4th level l04ag valid from january 2024.) | Saphnelo 300 mg/2 mL injection, 2 mL vial | Solution concentrate for I.V. infusion 300 mg in 2 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | AstraZenecaPtyLtd |
| Australia | (L04AG11) anifrolumab (adm: P, previous atc code l04aa51. new atc 4th level l04ag valid from january 2024.) | Saphnelo 300 mg/2 mL injection, 2 mL vial | Solution concentrate for I.V. infusion 300 mg in 2 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | AstraZenecaPtyLtd |
| Australia | (L04AG12) ofatumumab (adm: P) | Kesimpta 20 mg/0.4 mL injection, 0.4 mL pen device | Solution for injection 20 mg in 0.4 mL pre-filled pen, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L04AG12) ofatumumab (adm: P) | Kesimpta 20 mg/0.4 mL injection, 0.4 mL pen device | Solution for injection 20 mg in 0.4 mL pre-filled pen, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg tablet, 100 | Tablet 1 mg, 100 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection; Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 2 mg tablet, 100 | Tablet 2 mg, 100 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection; Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg/mL oral liquid, 60 mL | Oral solution 1 mg per mL, 60 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection; Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg/mL oral liquid, 60 mL | Oral solution 1 mg per mL, 60 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection; Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg/mL oral liquid, 60 mL | Oral solution 1 mg per mL, 60 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection; Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 500 microgram tablet, 100 | Tablet 0.5 mg, 100 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection; Kidney Transplantation | PfizerAustraliaPtyLtd |
| Australia | (L04AH01) sirolimus (adm: O) | Rapamune 1 mg tablet, 100 | Tablet 1 mg, 100 pcs | Retail price without vat |
$0-0 |
$0-0 |
Graft Rejection; Kidney Transplantation | PfizerAustraliaPtyLtd |
Pages
